Mallinckrodt Pharmaceuticals Blog

Kratom.org - Kratom Strains & Vendors Reviewed

Skip to content
  • Home
  • Achievements
  • Advocacy
  • Culture
  • History
  • Philanthropy
  • Website

Achievements

Angela Cody Named St. Louis Business Journal Diverse Business Leader

  • by Gena Holthaus
  • Posted on September 24, 2018January 2, 2019
  • Achievements

Angela Cody, Senior Manager, Inclusion and Diversity, at Mallinckrodt was named among 20 honorees in the St. Louis region recognized by the St. Louis Business Journal Diverse Business Leaders Awards. The awards highlight leadership in […]

Read More

NJBIA, New Jersey Business Magazine Recognize Mallinckrodt Pharmaceuticals Among Outstanding Redevelopment Projects

  • by Gena Holthaus
  • Posted on July 26, 2018September 24, 2018
  • Achievements

— Company Honored with New Good Neighbor Award on July 17 — The New Jersey Business & Industry Association (NJBIA) and New Jersey Business magazine honored Mallinckrodt Pharmaceuticals as one of 14 visionaries behind New […]

Read More

Mallinckrodt S&T Symposium: Cell Therapy Represents New Way Forward in Medicine

  • by Gena Holthaus
  • Posted on July 13, 2018
  • Achievements

Mallinckrodt Pharmaceuticals is an innovation-driven specialty pharmaceutical company focused on improving outcomes for patients with severe and critical conditions. Among the company’s most innovative areas of focus is regenerative medicine – cell therapy – and […]

Read More

Mallinckrodt Hobart, N.Y., Site Celebrates Earning Manufacturing Leadership Honors

  • by Gena Holthaus
  • Posted on July 10, 2018July 26, 2018
  • Achievements

Mallinckrodt earned recent recognition as a Frost & Sullivan Manufacturing Leadership Award winner for its outstanding achievement in three categories – Operational Excellence Leadership, Supply Chain Leadership and Sustainability Leadership, as covered previously when the […]

Read More

Posts navigation

Older posts
Newer posts
  • NICU Awareness Month: Experts Share Advice on What to Expect in the NICU

    September 30, 2020
  • Mallinckrodt Volunteers Assemble and Distribute PPE for the St. Louis Community

    August 19, 2020
  • MNK CEO Mark Trudeau on the Value of an Inclusive Workplace

    June 30, 2020
  • An Open Letter from Mallinckrodt CEO Mark Trudeau on Diversity and Inclusion

    June 3, 2020
  • Creating a sense of community during times of isolation: Patient advocacy groups respond to the COVID-19 crisis

    May 29, 2020

Featured Video

Categories

  • Achievements
  • Advocacy
  • Culture
  • History
  • Media
  • Philanthropy
  • Uncategorized

Latest Posts

NICU Awareness Month: Experts Share Advice on What to Expect in the NICU

Mallinckrodt Volunteers Assemble and Distribute PPE for the St. Louis Community

MNK CEO Mark Trudeau on the Value of an Inclusive Workplace

An Open Letter from Mallinckrodt CEO Mark Trudeau on Diversity and Inclusion

Creating a sense of community during times of isolation: Patient advocacy groups respond to the COVID-19 crisis

Subscribe via Email

Enter your email address to subscribe and receive notifications of new posts by email.

About Mallinckrodt Pharmaceuticals

Mallinckrodt is a global business that develops, manufactures, markets and distributes specialty pharmaceutical products and therapies. Areas of focus include autoimmune and rare diseases in specialty areas like neurology, rheumatology, nephrology, pulmonology and ophthalmology; immunotherapy and neonatal respiratory critical care therapies; and analgesics and hemostasis products. The company's core strengths include the acquisition and management of highly regulated raw materials and specialized chemistry, formulation and manufacturing capabilities. The company's Specialty Brands segment includes branded medicines and its Specialty Generics segment includes specialty generic drugs, active pharmaceutical ingredients and external manufacturing.

Visit Our Corporate Website

About Us

Products

Core Strengths

Corporate Social Responsibility

Investor Relations

Careers

Connect & Share

RSS
LinkedIn

Mallinckrodt, the 'M' brand mark, the Mallinckrodt Pharmaceuticals logo and other brands are trademarks of a Mallinckrodt company. © 2015 Mallinckrodt.

Mallinckrodt Pharmaceuticals is a registered business name of Mallinckrodt plc, which is registered in Ireland as a public limited company with registration number 522227 and has its registered office at Damastown, Mulhuddart, Dublin 15, Ireland.